Results 321 to 330 of about 164,448 (358)
In Europe, Omalizumab is indicated for the treatment of moderate to severe asthma, but not for IgE‐mediated food allergy. We assessed the impact of Omalizumab on efficacy, safety, and the quality of life (FA‐QoL) in patients with moderate to severe asthma and who have a history of anaphylaxis to peanut, tree nuts, fish, egg, milk, and/or wheat.
Stefania Arasi+14 more
wiley +1 more source
Molecular hydrogen mitigates traumatic brain injury-induced lung injury via NLRP3 inflammasome inhibition. [PDF]
Liu L+6 more
europepmc +1 more source
Nano-Spray-Drying of Cyclodextrin/Ibuprofen Complexes with Aerosolization-Enhancing Additives for Pulmonary Drug Delivery. [PDF]
Motzwickler-Németh A+4 more
europepmc +1 more source
Effects of Surface Charge of Inhaled Liposomes on Drug Efficacy and Biocompatibility. [PDF]
Zhang J+6 more
europepmc +1 more source
Phase 2 Study to Evaluate the Efficacy and Safety of Inhaled Nitric Oxide Therapy in Patients With Severe Right Heart Failure Associated With Pulmonary Hypertension - Protocol for the PHiNO Study. [PDF]
Ueda J+13 more
europepmc +1 more source
Lung volume assessment for mean dark-field coefficient calculation using different determination methods. [PDF]
Gassert FT+12 more
europepmc +1 more source